Clinical Trials

Biliary Tract Neoplasms

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

600 enrolled

Biliary Tract Neoplasms

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06037980 2025-02-17

PURITY

Phase 2/3 Recruiting

300 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT04720131 2024-01-30

Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.

28 enrolled

Biliary Tract Neoplasms

NCT03079427 2022-12-06

Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma

101 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Unknown

160 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

NCT04401709 2022-06-15

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

Phase 3 Unknown

490 enrolled

Biliary Tract Neoplasms

NCT03093870 2021-08-03

TreeTopp

Phase 2/3 Completed

151 enrolled 18 charts

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT03231176 2020-11-19

Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer

62 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT02773459 2019-09-30

MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer

Phase 1/2 Completed

31 enrolled

Biliary Tract Neoplasms

NCT02350686 2019-05-20

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Phase 2 Unknown

67 enrolled

Biliary Tract Neoplasms

NCT03609489 2018-08-09

A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Phase 2 Unknown

40 enrolled

Biliary Tract Neoplasms

NCT03082053 2018-06-28

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

24 enrolled

Biliary Tract Neoplasms

NCT03129074 2018-05-23

Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer

Phase 2 Withdrawn

Biliary Tract Neoplasms

NCT00142480 2018-04-25

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

8 enrolled

Biliary Tract Neoplasms

NCT02558959 2018-02-13

Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer

64 enrolled

Biliary Tract Neoplasms

NCT01843725 2018-01-31

MOMENTUM1

37 enrolled

BreastGastrointestinal

Biliary Tract Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02720601 2018-01-25

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Phase 2 Withdrawn

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT01572324 2017-01-04

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

37 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT00868998 2016-05-23

GTX Regimen for Biliary Cancers

Phase 2 Terminated

4 enrolled 7 charts

Biliary Tract Neoplasms

NCT01530503 2016-02-25

BIT-2

52 enrolled

Biliary Tract Neoplasms

NCT00630890 2015-09-11

Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)

Phase 1 Terminated

11 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT00551096 2013-12-25

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

23 enrolled

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT00338988 2012-08-01

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

44 enrolled 5 charts

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT00626158 2012-04-04

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

45 enrolled